Collegium Pharmaceutical
COLL
Cars.com
CARS
New Fortress Energy
NFE
4
Precision Drilling
PDS
5
Lantheus
LNTH
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -1.22%4.39B | -9.07%19.22B | 10.49%5.98B | -8.13%4.33B | -17.87%4.47B | -24.15%4.44B | -11.04%21.14B | -14.02%5.42B | -24.55%4.71B | -7.41%5.44B |
Operating revenue | -1.22%4.39B | -9.07%19.22B | 10.49%5.98B | -8.13%4.33B | -17.87%4.47B | -24.15%4.44B | -11.04%21.14B | -14.02%5.42B | -24.55%4.71B | -7.41%5.44B |
Cost of revenue | 14.91%2.57B | -17.76%10.36B | -23.10%2.53B | -39.06%2.23B | -7.82%12.59B | -6.32%3.29B | ||||
Gross profit | -17.47%1.82B | 3.72%8.86B | -9.87%1.94B | 0.64%2.21B | -15.39%8.55B | -9.02%2.15B | ||||
Operating expense | 3.65%1.87B | 2.83%7.29B | -10.42%1.5B | 2.09%1.81B | -7.39%7.09B | -6.57%1.68B | ||||
Selling and administrative expenses | 5.05%728M | 0.42%2.89B | 1.94%789M | -0.72%692M | 3.62%715M | -4.94%693M | -2.64%2.88B | -1.02%774M | -9.60%697M | -5.22%690M |
Research and development costs | 1.78%1.15B | 5.49%4.51B | 5.19%1.14B | 4.59%1.12B | 9.67%1.13B | 1.53%1.13B | -5.02%4.28B | -8.09%1.08B | -8.41%1.07B | -5.22%1.03B |
Provision for doubtful accounts | ---- | -2,540.00%-122M | ---- | ---- | ---- | ---- | -95.28%5M | ---- | ---- | ---- |
Other operating expenses | 91.67%-1M | 117.39%12M | ---- | ---- | -666.67%-345M | 82.35%-12M | -175.00%-69M | ---- | ---- | -104.55%-45M |
Operating profit | -111.88%-48M | 8.04%1.57B | 49.39%490M | 3.80%246M | -7.89%432M | -5.39%404M | -40.47%1.46B | -67.46%328M | -54.16%237M | -16.84%469M |
Net non-operating interest income expense | -80.70%11M | 72.09%74M | 150.00%27M | 400.00%57M | 134.40%43M | -200.00%-54M | ||||
Non-operating interest income | ---- | 17.16%478M | ---- | ---- | ---- | ---- | 134.48%408M | ---- | ---- | ---- |
Non-operating interest expense | ---- | -8.40%327M | ---- | ---- | ---- | ---- | 62.27%357M | ---- | ---- | ---- |
Total other finance cost | 80.70%-11M | 862.50%77M | ---- | ---- | -150.00%-27M | -400.00%-57M | -89.87%8M | ---- | ---- | 200.00%54M |
Other net income (expense) | 0.00%1M | 1,641.38%447M | 123.08%3M | 116.67%1M | 80.67%-29M | -116.67%-13M | ||||
Gain on sale of security | ---- | 152.53%83M | ---- | ---- | ---- | ---- | -167.80%-158M | ---- | ---- | ---- |
Earnings from equity interest | 0.00%1M | 117.95%7M | ---- | ---- | 123.08%3M | 116.67%1M | -50.00%-39M | ---- | ---- | -116.67%-13M |
Special income (charges) | ---- | 112.50%357M | ---- | ---- | ---- | ---- | 358.46%168M | ---- | ---- | ---- |
-Write off | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
-Gain on sale of business | ---- | 803.45%262M | ---- | ---- | ---- | ---- | 480.00%29M | ---- | ---- | ---- |
-Gain on sale of property,plant,equipment | ---- | -31.65%95M | ---- | ---- | ---- | ---- | 6,850.00%139M | ---- | ---- | ---- |
Income before tax | -107.78%-36M | 42.34%2.09B | 46.42%1.13B | 11.54%145M | 14.68%461M | 15.46%463M | -32.27%1.47B | -10.89%769M | -74.46%130M | -25.69%402M |
Income tax | 91.67%23M | -53.66%380M | -20.00%92M | -89.19%12M | 140.33%820M | 55.41%115M | ||||
Net income | -113.70%-60M | 89.10%1.28B | 2,640.63%813M | 31.58%175M | -149.13%-142M | 51.56%438M | -84.06%679M | -101.02%-32M | -68.93%133M | -37.17%289M |
Net income continuous Operations | -113.30%-60M | 163.64%1.71B | 1,562.75%746M | 11.54%145M | 28.92%370M | 55.52%451M | -84.55%649M | -101.62%-51M | -68.82%130M | -38.54%287M |
Net income discontinuous operations | --0 | -1,523.33%-427M | 252.63%67M | 933.33%31M | -25,700.00%-512M | -1,200.00%-13M | -47.37%30M | 72.73%19M | -72.73%3M | 128.57%2M |
Minority interest income | 0 | -50.00%7M | 400.00%3M | -60.00%4M | 55.56%14M | -133.33%-1M | ||||
Net income attributable to the parent company | -113.59%-59M | 92.03%1.28B | 1,852.17%806M | 31.58%175M | -150.34%-146M | 55.56%434M | -84.35%665M | -101.46%-46M | -68.85%133M | -36.54%290M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -113.59%-59M | 92.03%1.28B | 1,852.17%806M | 31.58%175M | -150.34%-146M | 55.56%434M | -84.35%665M | -101.46%-46M | -68.85%133M | -36.54%290M |
Basic earnings per share | -112.50%-0.01 | 91.67%0.23 | 1,600.00%0.15 | 33.35%0.0321 | -160.00%-0.03 | 60.00%0.08 | -84.21%0.12 | -101.79%-0.01 | -69.94%0.0241 | -37.50%0.05 |
Diluted earnings per share | -112.50%-0.01 | 91.67%0.23 | 1,600.00%0.15 | 50.00%0.03 | -160.00%-0.03 | 60.00%0.08 | -84.21%0.12 | -101.79%-0.01 | -75.00%0.02 | -37.50%0.05 |
Dividend per share | -0.32%0.03 | 18.32%0.1303 | -0.27%0.03 | -1.58%0.03 | 35.38%0.0402 | 51.48%0.0301 | 85.84%0.1101 | 53.78%0.0301 | 52.75%0.0304 | 50.42%0.0297 |
Currency Unit | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |